COVID-19 drug lead treatments identified
An international team of researchers has tested more than 10,000 compounds to identify six drug candidates that may help treat COVID-19.
The research, involving University of Queensland scientist Professor Luke Guddat, tested the efficacy of approved drugs, drug candidates in clinical trials and other compounds.
“Currently there are no targeted therapeutics or effective treatment options for COVID-19,” Professor Guddat said.
“In order to rapidly discover lead compounds for clinical use, we initiated a program of high-throughput drug screening, both in laboratories and also using the latest computer software to predict how different drugs bind to the virus.
Professor Guddat said the project targeted the main COVID-19 virus enzyme, known as the main protease or Mpro, which plays a pivotal role in mediating viral replication.
“This makes it an attractive drug target for this virus, and as people don’t naturally have this enzyme, compounds that target it are likely to have low toxicity.
“We add the drugs directly to the enzyme or to cell cultures growing the virus and assess how much of each compound is required to stop the enzyme from working or to kill the virus.
“If the amount is small, then we have a promising compound for further studies.”
After assaying thousands of drugs, researchers found of the six that appear to be effective in inhibiting the enzyme, one is of particular interest.
“We’re particularly looking at several leads that have been subjected to clinical trials including for the prevention and treatment of various disorders such as cardiovascular diseases, arthritis, stroke, atherosclerosis and cancer,” Professor Guddat said.
“Compounds that are already along the pipeline to drug discovery are preferred, as they can be further tested as antivirals at an accelerated rate compared to new drug leads that would have to go through this process from scratch.”
After the enzyme’s structure was made public, the team received more than 300 requests for more information, even before the paper was published.
“To provide an analogy, we’ve provided scientists with a fishing pole, the line and the exact bait, and have in only one month caught some fish,” Professor Guddat said.
“Now it’s up to us and the other fisherman – our fellow scientists globally – to take full advantage of this breakthrough.”
“With continued and up-scaled efforts we are optimistic that new candidates can enter the COVID-19 drug discovery pipeline in the near future.”
The international collaboration was led by researchers at ShanghaiTech University.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
COVID-19 treatment
- 'Just in case' antibiotics widely overused during COVID-19, says UN health agency
Antibiotics saw 'extensive overuse' globally among hospitalised COVID-19 patients during the pandemic without improving clinical outcomes, while also potentially increasing the already serious and ...
- Insurer in Coimbatore told to pay Rs 7L to widow of Covid-19 patient
COIMBATORE: The Coimbatore District Consumer Dispute Redressal Commission has ordered an insurance company to settle Rs 5 lakh claim to a petitioner whose 38-ye ...
- Antibiotics overused during Covid-19, says WHO: What this finding means for India
The highest antibiotic use was seen in patients with severe or critical Covid-19, with the global average standing at 81 per cent. And, they were most widely used in Eastern Mediterranean and African ...
- King Charles III to return to public duties amid ongoing cancer treatment
King Charles will resume engaging in public duties next week after nearly three months due to a cancer diagnosis.
- Study finds RSV treatment Beyfortus prevents 5,800 hospitalisations in France
French health authorities released two studies following their rollout of the new preventive antibody Beyfortus.
Go deeper with Google Headlines on:
COVID-19 treatment
[google_news title=”” keyword=”COVID-19 treatment” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
COVID-19
- ‘They’re never forgotten’: Brooklyn cemetery unveils COVID-19 memorial
Green-Wood Cemetery in Brooklyn is unveiling a new COVID memorial, offering a space for remembrance and solace to those who lost loved ones during the pandemic. Gustavo Padilla, a gravedigger at Green ...
- Andrew Cuomo agrees to testify to Congress on Covid-19 nursing home advisory
Former New York Gov. Andrew Cuomo, after being subpoenaed last month, has agreed to testify to Congress about his controversial nursing home advisory from the early days of the Covid-19 pandemic, Rep.
- Indiana dashboard adds 31 COVID deaths, 983 more cases of coronavirus in 2 weeks
Indiana’s COVID-19 death toll since March 2020 rose to 26,497 on Tuesday from 26,466 on April 9. That’s an increase of 31. Since Jan. 2, when the state reported 25,978 deaths, Indiana has recorded 519 ...
- COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle
Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants Pfizer, BioNTech, and CureVac, as GSK joins the fray, alleging patent ...
- Can Neosporin Protect You From Getting COVID-19?
A small study recently published in PNAS presents a similar, if lower-tech, idea. Coating the inside of the nose with the over-the-counter antibiotic ointment Neosporin seems to trigger an immune ...
Go deeper with Google Headlines on:
COVID-19
[google_news title=”” keyword=”COVID-19″ num_posts=”5″ blurb_length=”0″ show_thumb=”left”]